DelveInsight, the leading market research and consulting company has added new report “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016”to its portfolio.
Reports Highlights:
· CAR-T cell Therapy Pipeline scenario
· Collaborations & partnering deals
· Current Prominent Research Areas and Key Players
· Pipeline product profiles CAR-T Technologies and Targeted Antigens
· Licensing opportunities
· Market Drivers and Barriers
Report Coverage:
40+ companies,100+ products and 24 different technologies
DelveInsight Report, “Chimeric Antigen Receptor (CAR) T cell Immunot...